How cells' recycling centers and stress responses affect brain diseases

Regulation of lysosome positioning and function by the unfolded protein response

NIH-funded research Utah State Higher Education System--University of Utah · NIH-11173698

Researchers are looking at whether improving how cells' recycling centers (lysosomes) and stress responses clear toxic proteins could help people with Alzheimer's, Huntington's, or Parkinson's.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUtah State Higher Education System--University of Utah NIH-funded
Lab location1 site (Salt Lake City, United States)
Project IDNIH-11173698 on NIH RePORTER

What this research studies

This project uses lab-grown cells and model systems to learn how cells remove harmful, clumpy proteins that damage brain cells. Scientists will focus on lysosomes (the cell's recycling centers) and the unfolded protein response (the cell's stress alarm) to see how their placement and function affect clearance of toxic proteins. They will study pathways like microautophagy and how endoplasmic reticulum stress changes organelle trafficking. All work is done in research labs at the University of Utah and does not currently involve patient treatments.

Who could benefit from this research

Good fit: The project does not enroll patients, but people living with Alzheimer's disease, Huntington's disease, or Parkinson's disease are the populations who could benefit from eventual therapies arising from this work.

Not a fit: People without neurodegenerative disease or patients seeking immediate treatments are unlikely to see direct benefits from this lab-based research.

Why it matters

Potential benefit: If successful, this work could point to new ways to help brain cells clear toxic proteins and eventually slow or prevent neurodegenerative diseases.

How similar studies have performed: Laboratory studies targeting lysosome and autophagy pathways have shown promise in cell and animal models, but translating those findings into effective human treatments remains unproven.

Where this research is happening

Salt Lake City, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseCancers
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.